Collaborative Care for Depressed Elderly in Korea

Depression Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01626716
• Other study ID #: A102065_2012_1
• Status: Completed
• Phase: N/A
• First received: June 20, 2012
• Last updated: March 10, 2016
• Start date: June 2012
• Est. completion date: December 2013

Study information

• Verified date: March 2016
• Source: National Clinical Research Coordination Center, Seoul, Korea
• Contact: n/a
• Is FDA regulated: No
• Health authority: Korea:Ministry of Health and Welfare
• Study type: Interventional

Clinical Trial Summary

Late-life depression is associated with physical limitations, greater functional impairment, increased utilization and cost of health care, and suicide. Collaborative care, linking primary and mental health specialty care, has been shown to be effective for the treatment of late-life depression in primary care settings in Western countries. The primary aim of this project is to implement a depression care management intervention, and examine its effectiveness on the depressive symptoms of older patients in Korean primary care settings. Based on chronic disease management theory and previous Collaborative care management studies in western countries, we propose to test a Depression Care Management intervention,which includes care manager to support a primary care physician of depression in their old patients. Care manager'd role are monitoring the progress of treatment, supporting patient's adherence, educating patients/ family and facilitate communication between providers. Also psychiatrists provide consultation and supervision of care managers. Using a randomized controlled design, we will examine whether the Depression care management is an effective treatment for patients with late life depression in rural Korea. The primary outcome would be the improvement of depressive symptoms of patients in primary care setting.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: December 2013
• Est. primary completion date: December 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• 60 year or older

• diagnosed depression based on DSM-IV criteria

Exclusion Criteria:

• impairment of hearing

• dementia

• other psychiatric disorders

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Collaborative Care
• Depression
• Elderly
• Korean

Intervention

Other:
• care management
patients who assigned to the intervention group will take 7 times phone calls from case manager

Locations

Country	Name	City	State
Korea, Republic of	Chungju community health care center	Chungju	ChoongBuk

Sponsors (1)

Lead Sponsor	Collaborator
National Clinical Research Coordination Center, Seoul, Korea

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Reduced depression symptoms	HAMD (Hamilton Depression Ratind Scale) Difference HAMD score between the intervention and control group from baseline to 3 month follow-up	3 months	No
Secondary	Depression response and remissionhealth related quality of life	HAMD (Hamilton Depression Ratind Scale) Depression response is defined by improvement 50% or more HAMD scores from baseline to each follow-up periods.; Depression remission is defined by 7 or less of HAMD score at each follow-up periods	3months and 6months	No
Secondary	Reduced suicide ideation	SSI (Beck's suicide ieation scale) Difference total SSI scores Between the two groups from baseline to each follow-up periods	3 months and 6 months	No
Secondary	Improvement of Quality of life	EQ5D Difference EQ5D scores Between the two groups from baseline to each follow-up periods	3 months and 6 months	No